Development and validation of a highly sensitive GC/MS method for the determination of buprenorphine and nor-buprenorphine in blood

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 3, 2011, Pages 588-591

  Papoutsis, Ioannis I ^a   Nikolaou, Panagiota D ^a   Athanaselis, Sotirios A ^a   Pistos, Constantinos M ^a   Spiliopoulou, Chara A ^a   Maravelias, Constantinos P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Blood; Buprenorphine; Derivatization; GC MS; Maintenance

Indexed keywords

ACETIC ANHYDRIDE; BUPRENORPHINE; NORBUPRENORPHINE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HUMAN; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION;

ANALGESICS, OPIOID; BUPRENORPHINE; CALIBRATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; TEMPERATURE;

EID: 78149499185     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.09.023     Document Type: Article

References (18)

1. Concheiro-Guisan M., Shakleya D.M., Huestis M.A. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry. Anal. Bioanal. Chem. 2009, 394:513-522.
2. Wang G., Vincent M., Rodrigues W., Agrawal A., Moore C., Barhate R., Abolencia E., Coulter C., Soares J., Zheng Y.F., Taylor C., Morjana N. Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogenous immunoassay for the detection of buprenorphine and norbuprenorphine in urine. J. Anal. Toxicol. 2007, 31:377-382.
3. Cowan A., Lewis J.W., Macfarlane I.R. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br. J. Pharmacol. 1977, 60:537-545.
4. Walsh S.L., Preston K.L., Stitzer M.L., Cone E.J., Bigelow G.E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin. Pharmacol. Ther. 1994, 55:569-580.
5. George S., George C., Chauhan M. The development and application of a rapid gas chromatography-mass spectrometry method to monitor buprenorphine withdrawal protocols. Forensic Sci. Int. 2004, 143:121-125.
6. Dole V.P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. J. Am. Med. Assoc. 1965, 193:80-84.
7. Lewis J.W. Buprenorphine. Drug Alcohol Depend. 1985, 14:363-372.
8. Mattick R.P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2003, 2:CD002207.
9. Obadia Y., Perrin V., Feroni I., Vlahov D., Moatti J.P. Injecting misuse of buprenorphine among French drug users. Addiction 2001, 96:267-272.
10. Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 2001, 121:65-69.
11. Gopal S., Tzeng T.B., Cowan A. Development and validation of a sensitive analytical method for the simultaneous determination of buprenorphine and norbuprenorphine in human plasma. Eur. J. Pharm. Biopharm. 2001, 51:147-151.
12. Pirnay S., Bouchonnet S., Hervé F., Libong D., Milan N., Athis P., Baud F., Ricordel I. Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study. J. Chromatogr. A 2004, 807:335-342.
13. Moody D.E., Laycock J.D., Spanbauer A.C., Crouch D.J., Foltz R.L., Josephs J.L., Amass L., Bickel W.K. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 1997, 21:406-414.
14. Hoja H., Marquet P., Verneuil B., Lotfi H., Dupuy J.L., Lachatre G. Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 1997, 21:160-165.
15. Cirimele V., Etienne S., Villain M., Ludes B., Kintz P. Evaluation of the One-Step™ ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens. Forensic Sci. Int. 2004, 143:153-156.
16. Favretto D., Frison G., Vogliardi S., Ferrara S.D. Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine in urine, blood and hair samples. Rapid Commun. Mass Spectrom. 2006, 20:1257-1265.
17. Oechsler S., Skopp G. Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes. Forensic Sci. Int. 2010, 195:73-77.
18. Wu C.H., Yang S.C., Wang Y.S., Chen B.G., Lin C.C., Liu R.H. Evaluation of various derivatization approaches for gas chromatography-mass spectrometry analysis of buprenorphine and norbuprenorphine. J. Chromatogr. A 2008, 1182:93-112.